About Us / Business Model
HRA Pharma has a proven track record of developing, registering and commercializing products in its key therapeutic areas of women's health, endocrine diseases, and cell therapy.
The company has thus chosen to concentrate its resources on areas of high added value, including drug development, regulatory affairs, international marketing and business development. For other essential activities, the company relies on contract relationships with specialized partner companies.
HRA Pharma distributes and markets its products either directly (in the European Union) or via license agreements. In addition to high-quality products, HRA Pharma prides itself on providing users and healthcare providers with comprehensive information and associated services.